Inventor
AKIRA SHIZUO
JP19 patents
⚠️ This page may combine multiple inventors who share the name “AKIRA SHIZUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JAPAN SCIENCE & TECH AGENCY
6 patentsUS7507872B2Mar 24, 2009
Transgenic toll-like receptor 9 (TLR9) mice
JAPAN SCIENCE & TECH AGENCY6 citations65
US7608750B2Oct 27, 2009
Nonhuman model animal unresponsive to immunopotentiating synthetic compound
JAPAN SCIENCE & TECH AGENCY4 citations62
US7557258B2Jul 7, 2009
Endotoxin-nonresponsive model animal
JAPAN SCIENCE & TECH AGENCY0 citations52
US7371921B2May 13, 2008
Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide
JAPAN SCIENCE & TECH AGENCY0 citations51
US7329795B2Feb 12, 2008
Model animals non-responsive to mycobacterial-origin lipoprotein/lipopeptide
JAPAN SCIENCE & TECH AGENCY0 citations51
US7078585B1Jul 18, 2006
Bacterial cell component-unresponsive model mouse
JAPAN SCIENCE & TECH AGENCY0 citations51
KISHIMOTO TADAMITSU
4 patentsUS5844082ADec 1, 1998
Human acute phase response factor
KISHIMOTO TADAMITSU25 citations92
US5719042AFeb 17, 1998
Nucleic acids encoding transcription factor APRF (acute phase response factor)
KISHIMOTO TADAMITSU16 citations81
US5360894ANov 1, 1994
C/EBP2 gene and recombinant C/EBP2
KISHIMOTO TADAMITSU6 citations70
US5215892AJun 1, 1993
C/EBP2 gene and recombinant C/EBP2
KISHIMOTO TADAMITSU11 citations70
JAPAN SCIENCE & TECH CORP
2 patentsAKIRA SHIZUO
2 patentsUS8894996B2Nov 25, 2014
Immunoadjuvant composition and use thereof
AKIRA SHIZUO3 citations57
US9400279B2Jul 26, 2016
Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
AKIRA SHIZUO0 citations45
UNIV OSAKA
2 patentsUS10172927B2Jan 8, 2019
Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
UNIV OSAKA0 citations48
US9732107B2Aug 15, 2017
Method for producing beta-hematin crystal comprising step of heating
UNIV OSAKA0 citations40